Patrik De Haes
Chairman Of The Board Of Directors at Oxurion NV- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Full professional proficiency
-
French Full professional proficiency
-
German Full professional proficiency
-
Dutch Native or bilingual proficiency
Topline Score
Bio
Errol Flynn Thompson
Patrick was and awesome Boss and person and he always looked out for his workers.
Errol Flynn Thompson
Patrick was and awesome Boss and person and he always looked out for his workers.
Errol Flynn Thompson
Patrick was and awesome Boss and person and he always looked out for his workers.
Errol Flynn Thompson
Patrick was and awesome Boss and person and he always looked out for his workers.
Experience
-
Oxurion NV
-
Belgium
-
Biotechnology Research
-
1 - 100 Employee
-
Chairman Of The Board Of Directors
-
May 2021 - Present
-
-
CEO
-
2007 - May 2021
Public Biotech Company listed on Brussels stock exchange (OXUR) focused on Diabetic Eye Disease
-
-
-
Biobrewhouse
-
Leuven, Flemish Region, Belgium
-
Co-Founder
-
Jun 2022 - Present
Biobrewhouse is a non profit to help prosper the local BioTech MedTech community in a collaboration between KU Leuven R&D, Leuven Mindgate and Flandersbio Biobrewhouse is a non profit to help prosper the local BioTech MedTech community in a collaboration between KU Leuven R&D, Leuven Mindgate and Flandersbio
-
-
-
Oncurious NV
-
Leuven, Flemish Region, Belgium
-
Co- Founder and Executive Chairman
-
2016 - May 2021
Private Biotech Company in Partnership with VIB ( Flemish Institute of Biotechnology) focused on second generation Immuno Oncology Private Biotech Company in Partnership with VIB ( Flemish Institute of Biotechnology) focused on second generation Immuno Oncology
-
-
-
flanders.bio
-
Belgium
-
Biotechnology Research
-
1 - 100 Employee
-
Chairman Of The Board
-
2012 - 2014
Life sciences cluster organisation for Flanders Life sciences cluster organisation for Flanders
-
-
-
Roche
-
Switzerland
-
Biotechnology Research
-
700 & Above Employee
-
VP Global Insulin Infusion Business Unit
-
2003 - 2006
Global Disetronic Diabetes business was bought by Roche in 2003 Global Disetronic Diabetes business was bought by Roche in 2003
-
-
-
Disetronic Medical Systems
-
Medical Equipment Manufacturing
-
1 - 100 Employee
-
President and CEO
-
1996 - 2003
Medical Device company focused on Insulin Infusion and Glucose Measurement Medical Device company focused on Insulin Infusion and Glucose Measurement
-
-
-
Sandoz
-
Switzerland
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Global Product Manager Biotechnology
-
1990 - 1994
Lead the team that developed GM-CSF
-
-
Head Global Medical Operations
-
1987 - 1990
Responsible for Immunology, Allergology and Infectious Diseases
-
-
Education
-
Cardiff University / Prifysgol Caerdydd UK
Postgraduate Course in Pharmaceutical Medicine -
Faculteit Geneeskunde KU Leuven Faculty of Medicine
Doctor of Medicine - MD, magna cum laude -
University of St Thomas - Minnesota
Executive MBA